Previous success using lipidated TLR7/8 agonists by other groups, namely 3M-052 (43) and 1V270 (58), led us to hypothesize that these novel imidazoquinolines may serve as potent adjuvants for influenza vaccination in mice. The gene discussed is TLR7; the disease is influenza.